Statements (49)
Predicate | Object |
---|---|
gptkbp:instance_of |
gptkb:Research_Institute
|
gptkbp:affiliated_with |
gptkb:Queen_Mary_University_of_London
|
gptkbp:collaborates_with |
NHS hospitals
|
gptkbp:conducts |
clinical trials
|
gptkbp:established_in |
gptkb:2010
|
gptkbp:focuses_on |
cancer research
|
gptkbp:has_departments |
gptkb:Clinical_Trials
Translational Research Cancer Biology |
gptkbp:has_research_focus |
gptkb:immunotherapy
gptkb:Oncology gptkb:guidelines gptkb:Health_Insurance palliative care patient education public health quality of life biomarkers community outreach patient care personalized medicine advocacy multidisciplinary teams healthcare delivery targeted therapies radiotherapy chemotherapy tumor microenvironment clinical outcomes health economics brain tumors survivorship patient-reported outcomes cancer stem cells cancer genetics cancer metabolism gastrointestinal cancer head and neck cancer pediatric cancers sarcomas cancer epigenetics |
https://www.w3.org/2000/01/rdf-schema#label |
Barts Cancer Institute
|
gptkbp:located_in |
gptkb:London
|
gptkbp:offers |
Ph D programs
|
gptkbp:provides |
clinical services
|
gptkbp:receives_funding_from |
gptkb:Cancer_Research_UK
|
gptkbp:bfsParent |
gptkb:Barts_Health_NHS_Trust
gptkb:St_Bartholomew's_Hospital |
gptkbp:bfsLayer |
6
|